Get started
BIOARCTIC ABBIOARCTIC ABBIOARCTIC AB

BIOARCTIC AB

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsETFs

Live chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.86 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
24.16
Basic EPS (TTM)
1.27 USD
Net income (FY)
‪−15.94 M‬ USD
Revenue (FY)
‪23.16 M‬ USD
Shares float
‪39.38 M‬
Beta (1Y)
0.37

Employees


Employees (FY)
107
Change (1Y)
+19 +21.59%
Revenue / Employee (1Y)
‪216.46 K‬ USD
Net income / Employee (1Y)
‪−148.94 K‬ USD

About BioArctic AB Class B


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Gunilla Christina Osswald
Website
bioarctic.se
Headquarters
Stockholm
Founded
2000
ISIN
SE0010323311
FIGI
BBG01BJQLSZ3
BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors in 2003 and is headquartered in Stockholm, Sweden.

Check out other big names from the same industry as BRCTF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs


SCZ
iShares MSCI EAFE Small-Cap ETF
Weight
0.04%
Market value
‪4.19 M‬
USD
VSS
Vanguard FTSE All-World ex-US Small-Cap ETF
Weight
0.03%
Market value
‪4.18 M‬
USD
VGK
Vanguard FTSE Europe ETF
Weight
0.01%
Market value
‪2.88 M‬
USD
XXSC
Xtrackers MSCI Europe Small Cap UCITS ETF Capitalisation 1C
Weight
0.09%
Market value
‪2.75 M‬
USD
SCHC
Schwab International Small-Cap Equity ETF
Weight
0.05%
Market value
‪2.52 M‬
USD
2B78
iShares Healthcare Innovation UCITS ETF
Weight
0.15%
Market value
‪1.56 M‬
USD
AVDV
Avantis International Small Cap Value ETF
Weight
0.01%
Market value
‪796.06 K‬
USD
IEUR
iShares Core MSCI Europe ETF
Weight
0.01%
Market value
‪783.24 K‬
USD
AGED
iShares Ageing Population UCITS ETF
Weight
0.13%
Market value
‪734.59 K‬
USD
DIHP
Dimensional International High Profitability ETF
Weight
0.01%
Market value
‪516.46 K‬
USD
SMC
SPDR MSCI Europe Small Cap UCITS ETF (Ireland)
Weight
0.09%
Market value
‪357.80 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of BRCTF is 32.16 USD — it has increased by 5.02% in the past 24 hours. Watch BIOARCTIC AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange BIOARCTIC AB stocks are traded under the ticker BRCTF.
BRCTF stock has fallen by −5.98% compared to the previous week, the month change is a 9.05% rise, over the last year BIOARCTIC AB has showed a 111.58% increase.
We've gathered analysts' opinions on BIOARCTIC AB future price: according to them, BRCTF price has a max estimate of 37.63 USD and a min estimate of 23.32 USD. Watch BRCTF chart and read a more detailed BIOARCTIC AB stock forecast: see what analysts think of BIOARCTIC AB and suggest that you do with its stocks.
BRCTF reached its all-time high on Sep 3, 2025 with the price of 36.83 USD, and its all-time low was 12.94 USD and was reached on Nov 12, 2024. View more price dynamics on BRCTF chart.
See other stocks reaching their highest and lowest prices.
BRCTF stock is 4.78% volatile and has beta coefficient of 0.37. Track BIOARCTIC AB stock price on the chart and check out the list of the most volatile stocks — is BIOARCTIC AB there?
Today BIOARCTIC AB has the market capitalization of ‪2.86 B‬, it has decreased by −1.69% over the last week.
Yes, you can track BIOARCTIC AB financials in yearly and quarterly reports right on TradingView.
BIOARCTIC AB is going to release the next earnings report on Nov 13, 2025. Keep track of upcoming events with our Earnings Calendar.
BRCTF earnings for the last quarter are 0.11 USD per share, whereas the estimation was 0.16 USD resulting in a −29.22% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about BIOARCTIC AB earnings.
BIOARCTIC AB revenue for the last quarter amounts to ‪41.25 M‬ USD, despite the estimated figure of ‪38.54 M‬ USD. In the next quarter, revenue is expected to reach ‪14.77 M‬ USD.
BRCTF net income for the last quarter is ‪10.16 M‬ USD, while the quarter before that showed ‪101.33 M‬ USD of net income which accounts for −89.98% change. Track more BIOARCTIC AB financial stats to get the full picture.
As of Oct 18, 2025, the company has 107 employees. See our rating of the largest employees — is BIOARCTIC AB on this list?
Like other stocks, BRCTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOARCTIC AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOARCTIC AB technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOARCTIC AB stock shows the buy signal. See more of BIOARCTIC AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.